Boston Scientific Announces 2021 Investor Day Meeting
Rhea-AI Summary
Boston Scientific Corporation (BSX) will hold a hybrid investor meeting on September 22, 2021, from 8:30 a.m. to 12:30 p.m. EDT, to discuss its financial goals and growth strategies. The meeting will feature business unit overviews, updates on product pipelines, and highlights from key segments including Cardiovascular, MedSurg, and Rhythm and Neuro. Interested parties can register for the live event in Boston or join via webcast. A replay will be available for one year post-event.
Positive
- Announcement of a hybrid investor meeting indicates transparency and engagement with the investor community.
- Focus on discussing financial goals and long-term growth strategies could reassure investors about future outlook.
Negative
- None.
News Market Reaction – BSX
In the trading session that priced this news, BSX declined 0.22%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MARLBOROUGH, Mass., Sept. 9, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will host a meeting with the investor community to review its financial goals and long-term growth strategies on Wednesday, September 22, 2021, from 8:30 a.m. – 12:30 p.m. EDT. Company leaders will also provide business unit market overviews, pipeline updates and spotlight key products from the company's Cardiovascular, MedSurg and Rhythm and Neuro segments.
The meeting will be held in hybrid format, live in Boston as well as a simultaneous webcast. Investors and other interested parties may register for the live meeting or webcast by visiting the events and presentations section on the company's investor website at http://investors.bostonscientific.com. A replay and summary materials from the presentations will also be available online for approximately one year following the event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.
CONTACTS | |
Media: | Investors: |
Kate Haranis | Lauren Tengler |
508-683-6585 (office) | 508-683-4479 (office) |
Media Relations | Investor Relations |
Boston Scientific Corporation | Boston Scientific Corporation |
View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-2021-investor-day-meeting-301372620.html
SOURCE Boston Scientific Corporation